Dashboard Navigation Menu
This dashboard displays cancer staging percentages for rolling five-year periods since 2016 for cancers. Staging describes the severity of a cancer diagnosis. Early stage is limited to its original location and is more easily treatable. Late Stage is more advanced, with the cancer having spread from the original location, and requires more aggressive treatment. Use the "Stage" filter to select either "Early" or "Late" Staging. Select additional options under “Year”, “Geography”, “Locality/Health District”, “Sex”, “Race”, and “Cancer Site” to filter the data further. You may also click on a specific locality/health district to reveal filtered data based on selections. Please refer to the 'About the Data' section below the dashboard for more information and definitions used.
-
Request Data
Staging Data
Data Source: Staging data come from the Virginia Cancer Registry 1995-2022.
Software: The counts and rates are generated using Surveillance, Epidemiology, and End Results (SEER)*STAT software.
Population Estimates: Population estimates are obtained from SEER*Stat Database: Populations - Total U.S. (1969-2022), released March 2025. The National Cancer Institute (NCI) procures and maintains U.S. population data for the denominators of cancer incidence rates.
Age-adjusted Rates: Age-adjusted rates are presented as hospitalizations per 100,000 population. Incidence rates are adjusted (weighted) to the proportion of persons in each age group. The standard age-distribution of the U.S. population in 2000 is used to calculate age-adjusted rates. The benefit of age-adjusted rates compared with unadjusted (crude) rates is it allows for comparisons across groups (geography, ethnicity, race, and sex) of different age compositions.
Race/Ethnicity: Data are shown for All races, Black (non-Hispanic) only, White (non-Hispanic) only, and Hispanic (all races). Hispanic data for incidence began being reliably reported to the Virginia Cancer Registry in 2016. American Indian/Alaskan Native and Asian/Pacific Islander are currently included in All Races. The Virginia Cancer Registry is continuing to work on improving race/ethnicity classifications.
Sex: Sex is presented as Male, Female, or both Male and Female.
Sex-specific Cancers: Staging percentages for sex-specific cancer sites (Breast, Cervix Uteri, Corpus and Uterus NOS, Ovary, and Prostate) only reflect data for that sex-specific population (i.e., breast cancer staging percentages only include female population data). Data are not displayed when the sex indicator is set to “Male and Female” and a sex-specific cancer site is selected.
Cancer Types:
- All Sites: includes all malignant cancers and urinary bladder cancer
- Brain and Other Nervous System: tumors in the brain and spinal cord
- Cervix Uteri: cancer that develops in the cervix, the lower part of the uterus that connects to the vagina
- Colorectal: a type of cancer that develops in the colon or rectum. It includes cecum, appendix, ascending colon, hepatic flexure, transverse colon, splenic flexure, descending colon, sigmoid colon, large intestine (not otherwise specified), rectosigmoid junction, and rectum
- Corpus and Uterus, not otherwise specified (NOS): cancer of the body of the uterus
- Esophagus: cancer that develops in the esophagus
- Female Breast: cancer that develops in the breast tissue
- Hodgkin Lymphoma: a type of cancer that affects the lymphatic system and it includes Hodgkin-nodal and Hodgkin-extra nodal
- Kidney and Renal Pelvis: cancer that develops in the kidney or renal pelvis
- Leukemia: cancer of the body's blood-forming tissues and it includes acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia, other lymphocytic leukemia, acute myeloid leukemia (AML), acute monocytic leukemia, chronic myeloid leukemia, other myeloid/monocytic leukemia, other acute leukemia, aleukemic, subleukemic and not otherwise specified
- Liver and Intrahepatic Bile Duct: cancer that forms in the bile ducts within the liver.
- Lung & Bronchus: cancer that starts in the lungs or the airways (bronchi) that lead to the lungs
- Melanoma of the Skin: skin cancer that develops in melanocytes
- Myeloma: type of blood cancer that develops from plasma cells in the bone marrow
- Non-Hodgkin Lymphoma (NHL): cancer that originates in the lymphatic system. Includes NHL-Nodal and NHL-Extra Nodal.
- Oral Cavity & Pharynx: type of head and neck cancer that affects the mouth and throat. It includes lip, tongue, salivary gland, floor of mouth, gum and other mouth, nasopharynx, tonsil, oropharynx, hypopharynx, and other oral cavity & pharynx
- Ovary: cancer that develops in the ovaries, fallopian tubes, or peritoneum (the lining of the abdominal cavity)
- Pancreas: cancer that develops in the pancreas
- Prostate: cancer that develops in the prostate gland
- Stomach: cancer that arises in the stomach lining
- Thyroid: cancer that develops in the thyroid gland
- Urinary Bladder: cancer that develops in the cells lining the bladder
Staging Definitions:
- Early stage refers to cancer that is early in its growth and is representative of localized cancers.
- Late stage refers to cancer that is further along in its growth and includes both regional and distant cancers.
- Localized cancer is usually found only in the tissue or organ where it began and has not spread to nearby lymph nodes or to other parts of the body.
- Regional stage refers to cancer that has grown beyond the original (primary) tumor to nearby lymph nodes or organs and tissues.
- Distant stage refers to cancer that has been spread from the original (primary) tumor to distant organs or distant lymph nodes. Also known as distant metastasis.
- In Situ stage refers to abnormal cells that are present but have not spread from the original (primary) tumor to nearby tissue. In situ stage and localized state are combined into early stage only for urinary bladder cancer.
Other: Data are produced and processed from sources believed to be reliable and accurate at that point of time. Additionally, The Virginia Cancer Registry (VCR) improved their quality assurance process on cancer incidence data. We reviewed and and ensured patient residence information reported by healthcare providers, including hospitals, clinics, physician's offices, and laboratories were accurate, using a mapping tool recommended by the North American Association of Central Cancer Registries (NAACCR). The Virginia Cancer Registry continues to assess variations using a 95% confidence interval. Unknown/Unreported variables were removed from the tables. Counts and rates based on cases fewer than 16 are not shown in accordance with suppression rules by the US Cancer Statistics, Centers for Disease Control and Prevention.